Annual Total Expenses
$114.36 M
+$42.70 M+59.59%
December 31, 2023
Summary
- As of February 7, 2025, EWTX annual total expenses is $114.36 million, with the most recent change of +$42.70 million (+59.59%) on December 31, 2023.
- During the last 3 years, EWTX annual total expenses has risen by +$97.17 million (+565.18%).
- EWTX annual total expenses is now at all-time high.
Performance
EWTX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$40.43 M
+$2.33 M+6.10%
September 30, 2024
Summary
- As of February 7, 2025, EWTX quarterly total expenses is $40.43 million, with the most recent change of +$2.33 million (+6.10%) on September 30, 2024.
- Over the past year, EWTX quarterly total expenses has increased by +$10.98 million (+37.28%).
- EWTX quarterly total expenses is now at all-time high.
Performance
EWTX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
EWTX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +59.6% | +37.3% |
| 3 y3 years | +565.2% | +37.3% |
| 5 y5 years | +1052.3% | +37.3% |
EWTX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +164.6% | at high | +215.3% |
| 5 y | 5-year | at high | +1052.3% | at high | +1144.8% |
| alltime | all time | at high | +1052.3% | at high | +1144.8% |
Edgewise Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $40.43 M(+6.1%) |
| Jun 2024 | - | $38.11 M(+9.7%) |
| Mar 2024 | - | $34.75 M(+2.6%) |
| Dec 2023 | $114.36 M(+59.6%) | $33.86 M(+15.0%) |
| Sep 2023 | - | $29.45 M(+16.2%) |
| Jun 2023 | - | $25.34 M(-1.4%) |
| Mar 2023 | - | $25.70 M(+16.4%) |
| Dec 2022 | $71.66 M | $22.08 M(+20.9%) |
| Sep 2022 | - | $18.26 M(+10.7%) |
| Jun 2022 | - | $16.49 M(+11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $14.83 M(+15.6%) |
| Dec 2021 | $43.22 M(+151.4%) | $12.82 M(-1.9%) |
| Sep 2021 | - | $13.08 M(+25.0%) |
| Jun 2021 | - | $10.46 M(+52.5%) |
| Mar 2021 | - | $6.86 M(+8.1%) |
| Dec 2020 | $17.19 M(+73.2%) | $6.34 M(+74.1%) |
| Sep 2020 | - | $3.64 M(-7.9%) |
| Jun 2020 | - | $3.96 M(+21.8%) |
| Mar 2020 | - | $3.25 M |
| Dec 2019 | $9.92 M | - |
FAQ
- What is Edgewise Therapeutics annual total expenses?
- What is the all time high annual total expenses for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual total expenses year-on-year change?
- What is Edgewise Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly total expenses year-on-year change?
What is Edgewise Therapeutics annual total expenses?
The current annual total expenses of EWTX is $114.36 M
What is the all time high annual total expenses for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual total expenses is $114.36 M
What is Edgewise Therapeutics annual total expenses year-on-year change?
Over the past year, EWTX annual total expenses has changed by +$42.70 M (+59.59%)
What is Edgewise Therapeutics quarterly total expenses?
The current quarterly total expenses of EWTX is $40.43 M
What is the all time high quarterly total expenses for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly total expenses is $40.43 M
What is Edgewise Therapeutics quarterly total expenses year-on-year change?
Over the past year, EWTX quarterly total expenses has changed by +$10.98 M (+37.28%)